First-in-Human Single Ascending Dose of SHR0302

Clinical trial NCT02423538 · UNKNOWN

Trial details

NCT number: NCT02423538
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2015-04-01
Primary completion: 2016-07-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.